WCG, a provider of clinical research services, launched its new brand identity representing the integration of WCG’s companies and its commitment to partner with stakeholders to bring therapies to patients, faster.

As clinical trials face new global headwinds, WCG said that it is uniquely positioned to help the clinical research industry succeed through its three brand pillars: connectivity, data intelligence, and expertise.

• WCG supports connectivity throughout the clinical trial ecosystem with technology solutions, services, data, and expertise to help enable sponsors, CROs, sites, and trial participants to collaborate in navigating increasingly complex protocol requirements.

• WCG leverages data intelligence to help enable clinical trial success. Insights and predictive analytics help clients to detect meaningful patterns, from recruitment trends to historical site performance, to data anomalies and potential safety issues. 

• WCG’s domain expertise help accelerate the development of therapies by improving the conduct and quality of clinical trials.

“WCG began as an ethical review company 55 years ago,” said Sam Srivastava, CEO WCG. “While our origins include pioneering work in that area, through strategic acquisitions and organic growth we have accumulated unmatched domain expertise and evolved into a trusted partner supporting our clients throughout the clinical trial journey. Our new look and feel better reflect our true identity as a leader providing the connectivity, data intelligence, and expertise required to successfully advance clinical research.”

Carmin Gade, chief marketing officer, said, “Our rebranding is more than a new logo,” said Carmin Gade, chief marketing officer. We’ve transformed from the inside out to ensure we’re streamlined and efficient in serving our clients. Our purpose-fit solutions enable the successful advancement of research protocols aimed at improving global health on a massive scale. In 2022, we touched 90 percent of all clinical trials globally.”